About us
Client Terms and Conditions
All Insource Purchase Orders are subject to our terms and conditions. Please see below links to each of our Terms and Conditions for your reference.
Main Terms and Conditions:
Supplementary Terms and Conditions:
- Insource Products Software Licence Agreement
- Insource Products End User Licence Agreement
- Fixed Price Contract SLA Supplementary T&Cs
- Time Materials SLA Supplementary T&Cs
- LEEP Support SLA Supplementary T&Cs
- Structured Training Course SLA Supplementary T&Cs
- Insource Data as a Service Terms and Conditions
- Insource Infrastructure Managed Services Terms and Conditions
- Standard Support Service Level Agreement
- Standard Support Plus Service Level Agreement
- Enhanced Support Service Level Agreement
- AppGuard License Managed Services Agreement
- Download our Carbon Reduction Plan
The term ‘Insource’ or ‘us’ or ‘we’ refers to Insource Ltd whose registered office is Insource House, 4 Southern Court, South Street, Reading, Berkshire, RG1 4QS. Our company registration number is 03835180, registered in England. The term ‘you’ refers to the user of our products or services.
We are DTAC compliant, our accreditations include:
At Insource we constantly strive for excellence and are proud of our achievements. Below are some of them:
Latest Insights
Waiting list grows again
The English referral-to-treatment (RTT) waiting list grew by a total of 60,000 patient pathways in May. Analysis produced for Health Service Journal by Dr Rob Findlay, Director of Strategic Solutions at Insource Ltd and founder of Gooroo Ltd That month is typically...
Cancer pathways cannot afford to stand still amid recruitment freezes
Jason Harries, Chief Commercial Officer, Insource News coverage from the Health Service Journal (HSJ) has highlighted a worrying trend that cancer centres in almost every English region are increasingly freezing recruitment to oncology posts. More than half of cancer...
Beating cancer at scale with pathway transformation
The number of people diagnosed with cancer in the UK continues to grow and for the first time the number of annual new cases has passed 400,000. For many people, one of the most difficult parts of that journey is not the diagnosis itself, but the waiting that comes...